Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT Syndrome

Mayo Clinic Proceedings

Volumn 78, Issue 12, 2003, Pages 1479-1487

  Ackerman, Michael J ^a,b   Tester, David J ^b   Jones, Gregg S ^c   Will, Melissa L ^b   Burrow, Christopher R ^c   Curran, Mark E ^c  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c DNA Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ETHNIC GROUP; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; SUDDEN DEATH;

EID: 0345690174     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.12.1479     Document Type: Article

References (42)

1. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med. 2001;345:1473-1482.
2. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334-2351.
3. Ackerman MJ, Clapham DE. Ion channels-basic science and clinical disease [published correction appears in N Engl J Med. 1997;337:579]. N Engl J Med. 1997;336:1575-1586.
4. Ackerman MJ, Clapham DE. Ion channels-basic science and clinical disease [published correction appears in N Engl J Med. 1997;337:579]. N Engl J Med. 1997;336:1575-1586.
5. Fang J, Madhavan S, Alderman MH. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med. 1996;335:1545-1551.
6. Gillum RF. Sudden coronary death in the United States: 1980-1985. Circulation. 1989;79:756-765.
7. Cooper RS. Health and the social status of blacks in the United States. Ann Epidemiol. 1993;3:137-144.
8. Splawski I, Timothy KW, Tateyama M, et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002;297:1333-1336.
9. Roden DM, George AL Jr. The genetic basis of variability in drug responses. Nat Rev Drug Discov. 2002;1:37-44.
10. Roden DM. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res. 2001;50:224-231.
11. Spooner PM, Albert C, Benjamin EJ, et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation. 2001;103:2361-2364.
12. Roden DM, Spooner PM. Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis. J Cardiovasc Electrophysiol. 1999;10:1664-1683.
13. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 2003;421:634-639.
14. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17-23.
15. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795-803.
16. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805-811.
17. Bennett PB, Yazawa K, Makita N, George AL, Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683-685.
18. Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 1996;384:80-83.
19. Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175-187.
20. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104:569-580.
21. Ackerman MJ. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc. 1998;73:250-269.
22. Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000;102:1178-1185.
23. Roden DM. Acquired long QT syndromes and the risk of proarrhythmia. J Cardiovasc Electrophysiol. 2000;11:938-940.
24. Ackerman MJ. The long QT syndrome. Pediatr Rev. 1998;19:232-238.
25. Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation. 2002;105:1943-1948.
26. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics. 1998;51:86-97.
27. Jongbloed RJ, Wilde AA, Geelen JL, et al. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families. Hum Mutat. 1999;13:301-310.
28. Ackerman MJ, VanDriest SL, Ommen S, et al. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol. 2002;39:2042-2048.
29. Ackerman MJ, Siu BL, Stumer WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286:2264-2269.
30. Antonarakis SE, Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mutat. 1998;11:1-3.
31. Scherer CR, Lerche C, Decher N, et al. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia. Br J Pharmacol. 2002;137:892-900.
32. Pietila E, Fodstad H, Niskasaari E, et al. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol. 2002;40:511-514.
33. Study Group on Molecular Basis of Arrhythmias. Gene connection for the heart. Available at: http://pc4.fsm.it:81/cardmoc/. Accessibility verified October 28, 2003.
34. Spector PS, Curran ME, Zou A, Keating MT, Sanguinetti MC. Fast inactivation causes rectification of the IKr channel. J Gen Physiol. 1996;107:611-619.
35. Morais Cabral JH, Lee A, Cohen SL, Chait BT, Li M, Mackinnon R. Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain. Cell. 1998;95:649-655.
36. Furutani M, Trudeau MC, Hagiwara N, et al. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation. 1999;99:2290-2294.
37. Ficker E, Thomas D, Viswanathan PC, et al. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. Am J Physiol Heart Circ Physiol. 2000;279:H1748-H1756.
38. Paulussen A, Raes A, Matthijs G, Snyders DJ, Cohen N, Aerssens J. A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency. J Biol Chem. 2002;277:48610-48616.
39. Marx SO, Kurokawa J, Reiken S, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002;295:496-499.
40. Kurokawa J, Chen L, Kass RS. Requirement of subunit expression for cAMP-mediated regulation of a heart potassium channel. Proc Natl Acad Sci U S A. 2003;100:2122-2127.
41. Kubota T, Horie M, Takano M, et al. Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias. J Cardiovasc Electrophysiol. 2001;12:1223-1229.
42. Schulze-Bahr E, Schwarz M, Hauenschild S, et al. A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J Mol Med. 2001;79:504-509.